Data Bridge Market Research analyses that the Head lice treatment market was valued at USD 978.98 million in 2022 and is expected to reach USD 1,606.10 million by 2030, at a CAGR of 6.1% during the forecast period. "Pediculosis Capitis" dominates the type segment of the Head lice treatment market owing to the increasing prevalence of cardiac arrhythmias. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.